Navigation Links
Banning the drug Valdecoxib In India

The National Pharmaco Vigilance Advisory Committee has prohibited the sale and manufacture of the drug// Valdecoxib, indicated for arthritis and acute pain in India under the Drugs and Cosmetics Act.

Studies done abroad have indicated that the drug Valdecoxib is found to double the risk of heart attacks and strokes and also result in severe skin reactions.

Although some of the leading pharmaceutical companies have stopped manufacturing it and have withdrawn the drug from the Indian market, a few leading companies differ in opinion and have adopted a “wait and watch” approach as a result of which they have still not withdrawn the drug from the market.

Some of the leading drugs manufacturing companies in India also have a major market-share in the product, with sales amounting to Rs.25 crore another reason for their reluctance to withdraw the drug from the market.

According to US officials, the request for withdrawal of the drug was made by the FDA after seeking approval from a committee they had constituted for advice on the issue. Higher authorities in the Indian Drug Manufacturers Association however feel that based on US models, the drug should not be banned in India as each countries requirement are different and withdrawal and approval of drugs should be made accordingly.

'"/>




Page: 1

Related medicine news :

1. Banning Smoking in the Home Helps Infants
2. Doctors Ask MPs To Protect Human Rights By Banning Smoking In Enclosed Public Spaces
3. Punjab Plans of Banning Sex Determination Kit from US
4. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. AIDS Disaster in India is Imminent
7. Indian Prime Minister has successful Knee Replacement Surgery
8. International community warns India on HIV situation
9. India takes on foot-and-mouth disease by vaccinating animals
10. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
11. India to benefit from pharma companies move
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: